01
SPMT®
02
Bioactive Wound Gel
03
Oral Peptide Drugs
04
Collagen Mimetic Peptides
 We are focused on
saving lives lEARN mORE SPMT® (Synthetic Protein Materials Technology) Platform Technology We are pioneering breakthroughs for the unmet health care needs lEARN mORE Bioactive Wound Gel - FDA 510(k) premarket notification We are overcoming barriers to bring new options and transform the lives of patients Oral Peptide Drugs – MNT® (Modified Nano Particle Technology) Platform Technology lEARN mORE We are on for translational,
anti-aging and functional
cosmetics R&D Collagen mimetic peptides, Oxyresveratrol Formulation and Tyrosinase inhibitors lEARN mORE

Platform Technologies
for Oral Peptide Drug Design

Trademark Reg. & Patent Pending

Peniel sciences is developing two different proprietary platforms to design Orally delivered peptide drugs.

First Platform is called “Modified Nanoparticle Technology” (MNT®) which will enable the use of specially modified nanoparticles to enhance the stability and delivery of peptides via oral route.

Second Technology is called “Multiple Bridge Stabilization” (MBS®) which uses selective modifications and cyclization of peptide chain to enhance stability.

SPMT®(Synthetic Protein Materials Technology)
Design of amino acid/peptide-based biomaterials (Patent Pending)

  • null

    Medical & Cosmetic Application

    Collagen mimetic biomaterials (CMB) for Wound Care

  • null

    Peptide based Tyrosinase Inhibitors (PTIs)

    Skin whitening

  • null

    Medical Device

    Anti- bacterial Bandages & Masks

Our Mission
Our Strategy
Product Pipeline

Saving lives is our priority

Develop improved technologies and products by leveraging the unique properties of peptides and related biomolecules to address various health issues thereby improving the quality of human life.

MORE ABOUT US

IDENTIFY & RESEARCH

Identify products and technologies for different applications and research collaboration with topmost Universities/Institutions (e.g. MIT) and Pioneers in the field.

LICENSING & ACQUIRE

License products and technology from inventors and transform into a marketable solution. Then acquire IP rights, patents, and publications through R&D programs, collaboration and licensing.

PROCURE & PUBLISH

Procure funding and grants such as SBIR, NIH, NSF etc. for research programs and publish research findings and launch media campaigns.

New Internal Projects (July 2019)

PSA1 – Potent, receptor selective, and specific and most efficacious ligand for the melancortin 1 receptor(MC1R)

PSC1, PSC2, PSC3 – Next generation wound healing peptide conjugates

PSD1 – Purpose-built products for surgery and trauma

COMPANY VALUATION

$
0
M
PENIEL SCIENCES
$
0
M
PATENT / IP TRANSFER
$
0
M
MEDICAL DEVICE
$
0
M
COSMETIC RAW / MATERIAL SALES/ 3YR

We are working
for a better life

Our SPMT® platform enables incorporation of a variety of functional components into biomaterials for different biomedical applications.

View the latest news